After performing a prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET-CT) scan, a low-grade prostate adenocarcinoma (PCa) (Gleason 3 + 3) was diagnosed. The gene discussed is FOLH1; the disease is prostate adenocarcinoma.